Disease Term | Human Homologs | Mouse Homologs | Mouse Models | Homology Source | |||
congenital megabladder | MYOCD* | Myocd* | 2 models | Alliance of Genome Resources | |||
cystinuria | SLC3A1* | Slc3a1* | 4 models | Alliance of Genome Resources | |||
cystinuria | SLC7A9* | Slc7a9* | 2 models | Alliance of Genome Resources | |||
urinary bladder cancer | PTEN* | Pten* | 3 models | Alliance of Genome Resources | |||
bladder exstrophy | TP63 | Trp63* | 1 model | Alliance of Genome Resources | |||
urinary bladder cancer | CTNNB1 | Ctnnb1* | 4 models | Alliance of Genome Resources | |||
urinary bladder cancer | NCSTN | Ncstn* | 2 models | Alliance of Genome Resources | |||
bladder carcinoma | PMF1*, PMF1-BGLAP | Pmf1 | Alliance of Genome Resources | ||||
bladder disease | CHRM3* | Chrm3 | Alliance of Genome Resources | ||||
bladder neck obstruction | CYP19A1* | Cyp19a1 | Alliance of Genome Resources | ||||
bladder urothelial carcinoma | KDM6A* | Kdm6a | Alliance of Genome Resources | ||||
cystitis | TLR5* | Tlr5 | Alliance of Genome Resources | ||||
interstitial cystitis | ADRB2* | Adrb2 | Alliance of Genome Resources | ||||
interstitial cystitis | CSF1* | Csf1 | Alliance of Genome Resources | ||||
interstitial cystitis | NGF* | Ngf | Alliance of Genome Resources | ||||
overactive bladder syndrome | PENK* | Penk | Alliance of Genome Resources | ||||
overactive bladder syndrome | NGF* | Ngf | Alliance of Genome Resources | ||||
urinary bladder cancer | CDKN2A* | Cdkn2a | Alliance of Genome Resources | ||||
urinary bladder cancer | CDKN2B* | Cdkn2b | Alliance of Genome Resources | ||||
urinary bladder cancer | CHEK2* | Chek2 | Alliance of Genome Resources | ||||
urinary bladder cancer | CXCR2* | Cxcr2 | Alliance of Genome Resources | ||||
urinary bladder cancer | CYP1A1* | Cyp1a1 | Alliance of Genome Resources | ||||
urinary bladder cancer | CYP2C9*, CYP2C8, CYP2C18, CYP2C19 | Cyp2c29, Cyp2c37, Cyp2c38, Cyp2c39, Cyp2c50, Cyp2c55, Cyp2c65, Cyp2c66 | Alliance of Genome Resources | ||||
urinary bladder cancer | DAPK1* | Dapk1 | Alliance of Genome Resources | ||||
urinary bladder cancer | EPHX1* | Ephx1 | Alliance of Genome Resources | ||||
urinary bladder cancer | ERBB2* | Erbb2 | Alliance of Genome Resources | ||||
urinary bladder cancer | ERCC2* | Ercc2 | Alliance of Genome Resources | ||||
urinary bladder cancer | FANCA* | Fanca | Alliance of Genome Resources | ||||
urinary bladder cancer | FAS* | Fas | Alliance of Genome Resources | ||||
urinary bladder cancer | FASLG* | Fasl | Alliance of Genome Resources | ||||
urinary bladder cancer | FGF1* | Fgf1 | Alliance of Genome Resources | ||||
urinary bladder cancer | FGF2* | Fgf2 | Alliance of Genome Resources | ||||
urinary bladder cancer | FGFR2* | Fgfr2 | Alliance of Genome Resources | ||||
urinary bladder cancer | FGFR3* | Fgfr3 | Alliance of Genome Resources | ||||
urinary bladder cancer | FHIT* | Fhit | Alliance of Genome Resources | ||||
urinary bladder cancer | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
urinary bladder cancer | GSTP1* | Gstp1, Gstp2, Gstp3, Gstp-ps | Alliance of Genome Resources | ||||
urinary bladder cancer | GSTT1* | Gstt1 | Alliance of Genome Resources | ||||
urinary bladder cancer | H19* | ||||||
urinary bladder cancer | HRAS* | Hras | Alliance of Genome Resources | ||||
urinary bladder cancer | HSPA1A*, HSPA1B | Hspa1a, Hspa1b | Alliance of Genome Resources | ||||
urinary bladder cancer | IL1RN* | Il1rn | Alliance of Genome Resources | ||||
urinary bladder cancer | IL2* | Il2 | Alliance of Genome Resources | ||||
urinary bladder cancer | KDR* | Kdr | Alliance of Genome Resources | ||||
urinary bladder cancer | KRAS* | Kras | 1 model | Alliance of Genome Resources | |||
urinary bladder cancer | MAP2K4* | Map2k4 | Alliance of Genome Resources | ||||
urinary bladder cancer | MGMT* | Mgmt | Alliance of Genome Resources | ||||
urinary bladder cancer | MIR494* | Mir494 | Alliance of Genome Resources | ||||
urinary bladder cancer | MMP1* | Mmp1a, Mmp1b | Alliance of Genome Resources | ||||
urinary bladder cancer | MRE11* | Mre11a | Alliance of Genome Resources | ||||
urinary bladder cancer | MSH2* | Msh2 | Alliance of Genome Resources | ||||
urinary bladder cancer | ATP8* | mt-Atp8 | Alliance of Genome Resources | ||||
urinary bladder cancer | CYTB* | mt-Cytb | Alliance of Genome Resources | ||||
urinary bladder cancer | ND2* | mt-Nd2 | Alliance of Genome Resources | ||||
urinary bladder cancer | MTHFR* | Mthfr | Alliance of Genome Resources | ||||
urinary bladder cancer | MTR* | Mtr | Alliance of Genome Resources | ||||
urinary bladder cancer | MUC5B* | Muc5b | Alliance of Genome Resources | ||||
urinary bladder cancer | NAT2*, NAT1 | Nat1, Nat2, Nat3 | Alliance of Genome Resources | ||||
urinary bladder cancer | PLAU* | Plau | Alliance of Genome Resources | ||||
urinary bladder cancer | PLK1* | Plk1 | Alliance of Genome Resources | ||||
urinary bladder cancer | PMS2*, PMS2P1, PMS2P2, PMS2P6 | Pms2 | Alliance of Genome Resources | ||||
urinary bladder cancer | PTGS2* | Ptgs2 | Alliance of Genome Resources | ||||
urinary bladder cancer | RASSF1* | Rassf1 | Alliance of Genome Resources | ||||
urinary bladder cancer | RB1* | Rb1 | 1 model | Alliance of Genome Resources | |||
urinary bladder cancer | RUNX3* | Runx3 | Alliance of Genome Resources | ||||
urinary bladder cancer | SERPINE1* | Serpine1 | Alliance of Genome Resources | ||||
urinary bladder cancer | SLC11A1* | Slc11a1 | Alliance of Genome Resources | ||||
urinary bladder cancer | SOCS1* | Socs1 | Alliance of Genome Resources | ||||
urinary bladder cancer | SOX4* | Sox4 | Alliance of Genome Resources | ||||
urinary bladder cancer | SULT1A1*, SULT1A2, SULT1A3, SULT1A4 | Sult1a1 | Alliance of Genome Resources | ||||
urinary bladder cancer | TERT* | Tert | Alliance of Genome Resources | ||||
urinary bladder cancer | TGFBR1* | Tgfbr1 | Alliance of Genome Resources | ||||
urinary bladder cancer | TIMP3* | Timp3 | Alliance of Genome Resources | ||||
urinary bladder cancer | TLR2* | Tlr2 | Alliance of Genome Resources | ||||
urinary bladder cancer | TMEFF2* | Tmeff2 | Alliance of Genome Resources | ||||
urinary bladder cancer | TNFRSF10A*, TNFRSF10B, TNFRSF10C, TNFRSF10D | Tnfrsf10b | Alliance of Genome Resources | ||||
urinary bladder cancer | WIF1* | Wif1 | Alliance of Genome Resources | ||||
urinary bladder cancer | XDH* | Xdh | Alliance of Genome Resources | ||||
urinary bladder cancer | XRCC1* | Xrcc1 | Alliance of Genome Resources | ||||
urinary bladder cancer | PMF1*, PMF1-BGLAP | Pmf1 | Alliance of Genome Resources | ||||
urinary bladder cancer | AMACR* | Amacr | Alliance of Genome Resources | ||||
urinary bladder cancer | APEX1* | Apex1 | Alliance of Genome Resources | ||||
urinary bladder cancer | ATP5MC2* | Atp5mc2 | Alliance of Genome Resources | ||||
urinary bladder cancer | AXIN1* | Axin1 | Alliance of Genome Resources | ||||
urinary bladder cancer | BCL2* | Bcl2 | Alliance of Genome Resources | ||||
urinary bladder cancer | MYC* | Bmyc, Myc | Alliance of Genome Resources | ||||
urinary bladder cancer | BRCA1* | Brca1 | Alliance of Genome Resources | ||||
urinary bladder cancer | CASP9* | Casp9 | Alliance of Genome Resources | ||||
urinary bladder cancer | CDC25A* | Cdc25a | Alliance of Genome Resources | ||||
urinary bladder cancer | CDH13* | Cdh13 | Alliance of Genome Resources | ||||
urinary bladder cancer | CDK1* | Cdk1 | Alliance of Genome Resources | ||||
urinary bladder cancer | CDK4* | Cdk4 | Alliance of Genome Resources | ||||
urinary schistosomiasis | STAT6* | Stat6 | Alliance of Genome Resources | ||||
urinary schistosomiasis | CTLA4* | Ctla4 | Alliance of Genome Resources |
Transgenes and other genome features developed in mice to model this disease.
|
|||
Disease Term | Transgenes and Other Genome Features | Mouse Models | |
urinary bladder cancer | Tg(UPII-SV40T)29Xrw | 1 model | |
urinary bladder cancer | Tg(Upk2-TAg)1Rkl | 1 model | |
urinary bladder cancer | Tg(CAG-TRIM29)ADims | 1 model | |
urinary bladder cancer | Tg(KRT19-TAg)7Eps | 1 model | |
urinary bladder cancer | Tg(UPII-SV40T)2Xrw | 1 model |